Jan. 30, 2024, 11:55 a.m. | Rob Thubron

TechSpot www.techspot.com


Back in May last year, Neuralink, founded by Musk in 2016, was given permission by the Federal Drug Administration (FDA) to begin its first in-human clinical study, paving the way for a brain-machine interface with the potential to treat fatal neurological diseases, paralysis, blindness, and more. In September, the brain...

Read Entire Article

administration blindness brain clinical diseases elon elon musk fda human implant machine musk neuralink neuralink implant paralysis patient september study

Software Engineer for AI Training Data (School Specific)

@ G2i Inc | Remote

Software Engineer for AI Training Data (Python)

@ G2i Inc | Remote

Software Engineer for AI Training Data (Tier 2)

@ G2i Inc | Remote

Data Engineer

@ Lemon.io | Remote: Europe, LATAM, Canada, UK, Asia, Oceania

Artificial Intelligence – Bioinformatic Expert

@ University of Texas Medical Branch | Galveston, TX

Lead Developer (AI)

@ Cere Network | San Francisco, US